Press release content from PR Newswire. The AP news staff was not involved in its creation.
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative
May 6, 2021 GMT
(PRNewsfoto/DarwinHealth)
NEW YORK, May 6, 2021 /PRNewswire/ DarwinHealth, a New York City-based biotechnology company, today announced a scientific research collaboration with Bristol-Myers Squibb Company (NYSE: BMY). The research collaboration, the Novel Cancer Target Initiative (NCTI), employs quantitative systems biology-based algorithms, proprietary databases, and validated technologies to identify novel cancer targets (NCTs) across a range of tumor subtypes.
The methodology underpinning the NCTI is based on an understanding of critical mechanisms linked to tumor dependencies and maintenance beyond genetic mutations. To facilitate the discovery of NCTs, DarwinHealth will provide Bristol Myers Squibb proprietary information residing in its d